Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (A, B)
http://cb.hbsp.harvard.edu/cb/product/394202-PDF-ENG
Authors: Gentile, Mary C.; Grant, Sarah B.
Source: Harvard Business School
Year: 1995
Number of pages: 24, 3
Abstract:
Kurt Landgraf, newly named CEO of Du Pont Merck Pharmaceutical Co., addresses complaints of discrimination from African-American scientists in R&D during significant downsizing and dramatic changes within the pharmaceutical industry.
Case Available to Faculty Only. Faculty Member? Sign in / Register Here
This case is available for purchase from Harvard Business School Publishing Reference #: 394202, 395035